Clinical history of cancer-associated splanchnic vein thrombosis.

CONCLUSIONS: The risk of recurrent thrombosis and bleeding appears to be similar in cancer patients with SVT and cancer patients with usual site VTE, despite some differences in baseline characteristics and anticoagulant treatment. Further prospective studies are warranted to confirm these findings.
PMID: 33306241 [PubMed - as supplied by publisher]

Source: Thrombosis and Haemostasis - December 11, 2020 Category: Hematology Authors: Valeriani E, Di Nisio M, Riva N, Caiano LM, Porreca E, Bang SM, Beyer-Westendorf J, Sartori MT, Barillari G, Santoro R, Kamphuisen PW, Alatri A, Malato A, Vidili G, Oh D, Schulman S, Ageno W, International Registry on Splanchnic Vein Thrombosis (IRSVT) st Tags: J Thromb Haemost Source Type: research